Neoadjuvant pyrotinib plus trastuzumab and chemotherapy for HER2-positive breast cancer: a prospective cohort study

This prospective study aims to investigate the efficacy and safety of pyrotinib (P) combined with 4 cycles of epirubicin and cyclophosphamide followed by 4 cycles of taxane and trastuzumab (P  + EC-TH) regimen ...

Source: World Journal of Surgical Oncology - December 19, 2023 Category: Cancer & Oncology Authors: Lu Liu, Mingzhi Zhu, Yanyan Wang, Muhan Li and Yuanting Gu Tags: Research Source Type: research